Lineage Cell Therapeutics (LCTX) Current Leases (2014 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly Current Leases came in at $833000.0 in Q1 2026, down 25.89% year-on-year from $1.1 million in Q1 2025, and up 2.08% quarter-over-quarter from $816000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Current Leases (2014 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Current Leases history runs 13 years deep, the most recent figure standing at $833000.0 for Q1 2026.
- On a quarterly basis, Current Leases fell 25.89% year-over-year to $833000.0 in Q1 2026; TTM through Mar 2026 was $833000.0, a 25.89% decrease from a year earlier, with the FY2025 full-year figure at $816000.0, up 1383.64% from the prior year.
- Current Leases climbed to $833000.0 in Q1 2026 per LCTX's latest filing, from $816000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.1 million in Q1 2025 and bottomed at $31000.0 in Q1 2022.
- The 5-year median for Current Leases is $816000.0 (2025), against an average of $573941.2.
- Across the five-year window, Current Leases slumped 96.06% in 2022 and jumped 2841.94% in 2023, its largest moves.
- Year by year, Current Leases stood at $36000.0 in 2022, then soared by 2205.56% to $830000.0 in 2023, then tumbled by 93.37% to $55000.0 in 2024, then surged by 1383.64% to $816000.0 in 2025, then increased by 2.08% to $833000.0 in 2026.
- Per Business Quant, the three latest LCTX Current Leases figures stand at $833000.0 (Q1 2026), $816000.0 (Q4 2025), and $1.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn | 833,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 833,000.00 |
| Dec 31, 2025 | 816,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 830,000.00 |
| Sep 30, 2023 | 881,000.00 |
| Jun 30, 2023 | 933,000.00 |
| Mar 31, 2023 | 912,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 543,000.00 |
| Jun 30, 2022 | 593,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 801,000.00 |
| Sep 30, 2021 | 801,000.00 |
| Jun 30, 2021 | 790,000.00 |